FLEXIBLE SOLUTIONS INTERNATIONAL INC — Form 8-K
Filed September 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Flexible Solutions International announced the appointment of Dr. Kim Reid as director and audit committee member, effective immediately until the next Annual Meeting. Concurrently, long-tenured director John Bientjes resigned after nearly thirty years of service; David Fynn assumes Bientjes's Audit Committee Chair role. Dr. Reid brings expertise in biotech process development, GMP manufacturing, and mRNA-LNP production, with PhD in Biology and prior experience as a Canadian fighter pilot.
Why this rating
Routine board turnover. Dr. Reid's biotech expertise aligns with company's polymer/biotech business, but single director change is standard governance. No financial impact disclosed.
See more from September 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.